Our data showed that knocking down NIT1, but not NIT2, can decrease cell viability in various lung cancer cell lines, and that it can be rescued after NIT1 expression levels were restored with recombinant human Nit1 adenovirus. This evidence concerns the gene NIT2 and lung cancer.